Home » Healthcare » Pharmaceuticals » Trigeminal Neuralgia Treatment Market

Trigeminal Neuralgia Treatment Market By Treatment (Drug Based, Surgery) – Growth, Future Prospects And Competitive Analysis, 2017 – 2025

Published: | Report ID: 11788 | Report Format : PDF

Market Insights

This report on the global trigeminal neuralgia treatment market investigates various drugs used for trigeminal neuralgia treatment, as well as a pipeline analysis of upcoming potential drugs. Trigeminal neuralgia is a chronic pain condition that affects the trigeminal nerve, which carries sensation from the face to the brain.

According to the International Association for the Study of Pain, the incidence of trigeminal neuralgia is 12 per 100,000 people per year. The etiology includes the compression of blood vessels, degeneration of arteries, myelin sheath infiltration, and idiopathy.

Trigeminal neuralgia is most commonly seen after the age of 40 and is more common in women. Thus, the drug pipeline for the trigeminal neuralgia treatment market comprises potential drugs that are more target-specific and possess innovative properties.

For the purpose of this study, the various treatment types studied include drug-based therapy and surgical procedures; further, drug-based therapy is segmented as anticonvulsant drugs, NSAIDs, and opioids.

Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.

The pipeline analysis for the trigeminal neuralgia treatment market includes estimated market sales of Phase III drugs through 2025. We have estimated sales of very specific molecules based on the type (chemical-based or biological), sponsor, depicted peak sales by leading market experts, and other factors.

The global trigeminal neuralgia treatment market is segmented geographically into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa markets. The regions are also further sub-segmented on the basis of major countries. Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.

Trigeminal neuralgia is a chronic pain condition that affects the trigeminal nerve, which carries sensation from the face to the brain. The etiology includes the compression of blood vessels, degeneration of arteries, myelin sheath infiltration, and idiopathy. According to the American Association of Neurological Surgeons, 150,000 people are diagnosed with trigeminal neuralgia. Trigeminal neuralgia is most commonly seen after the age of 40.

Based on the treatment type, the trigeminal neuralgia treatment market is segmented into:

Drug-based

  • Anticonvulsant
  • NSAIDs
  • Opioids

Surgery

  • Rhizotomy
  • Stereotactic radiosurgery
  • Microvascular decompression

According to market experts, drug-based therapy is increasingly being used to treat in developed markets, but its use in emerging markets remains low. Carbamazepine is the only approved drug on the market and is considered first-line therapy, followed by NSAIDs and opioids.

However, the drug-related side effects are high, so patients are opting for various types of surgical procedures for the treatment of trigeminal neuralgia, like microvascular decompression, rhizotomy, and stereotactic radiosurgery. In the base year of 2016, drug-based therapy accounted for the major market share in the treatment industry at around 71%, followed by surgical procedures, which accounted for the remaining 29% of patients who were not responding to drug therapy.

During the forecast period of 2017–2025, drug-based therapy is expected to experience significant growth. The key factors assisting the segment’s growth comprise patient-supportive reimbursement policies that have assisted the increased use of drug-based therapy in developed markets, a rise in the aging population coupled with growing public awareness, and technological advancements in surgical procedures.

For the purpose of this study, the global trigeminal neuralgia treatment market is categorized into:

  •  North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

North America was observed as the largest market for trigeminal neuralgia treatment in the base year of 2016 due to a rise in the aging population and technological advancements in diagnostic tests. Europe is expected to be the second-largest market due to rising public awareness, healthcare infrastructure, and the penetration of new technologies.

According to the American Association of Neurological Surgeons, 150,000 people are diagnosed with trigeminal neuralgia. Growth in Asia-Pacific in the trigeminal neuralgia treatment market is attributed to factors like the rising prevalence of neuropathic pain diseases, increasing investments in R&D, and higher disposable income in these regions.

However, factors such as developing health infrastructure, increasing awareness among people about health care, and an aging population are going to fuel the rapid growth of the trigeminal neuralgia disease treatment market in Latin America, the Middle East, and Africa in the near future.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Trigeminal Neuralgia Treatment Market Portraiture
2.2 Global Trigeminal Neuralgia Treatment Market, by Treatment, 2016 (US$ Mn)
2.3 Global Trigeminal Neuralgia Treatment Market, by Geography, 2016 (Value %)

Chapter 3 Global Trigeminal Neuralgia Treatment Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Growing prevalence of chronic pain disorders have generated demand for Trigeminal Neuralgia Treatment
3.2.2 Rise in aging population and public awareness have generated demand for Trigeminal Neuralgia Treatment
3.3 Market Restraints
3.3.1 Insufficient funding in emerging markets and high cost involved in treatment of Trigeminal Neuralgia
3.4 Market Opportunities
3.4.1 Improved Healthcare expenditure due to patient oriented reimbursement policies and tapping market of unmet medical needs
3.5 Porter’s Five Forces Model
3.6 Attractive Investment Proposition
3.7 Market Competition Assessment: Trigeminal Neuralgia Treatment, by Key Players

Chapter 4 Global Trigeminal Neuralgia Treatment Market, By Type of Treatment
4.1 Introduction
4.2 Drug Based
4.2.1 Anticonvulsant
4.2.2 NSAIDs
4.2.3 Opioids
4.3 Surgery
4.3.1 Rhizotomy
4.3.2 Stereotactic radiosurgery
4.3.3 Micro vascular decompression

Chapter 5 Global Trigeminal Neuralgia Treatment Market, By Geography
5.1 Preface
5.2 North America
5.3 Europe
5.4 Asia Pacific
5.5 Latin America
5.6 Middle East and Africa

Chapter 6 Company Profiles
6.1 Allergan Plc
6.1.1 Allergan Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.2 Biogen, Inc.
6.2.1 Biogen, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.3 Kineta Inc.
6.3.1 Kineta Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.4 Merz Pharma GmbH & Co.
6.4.1 Merz Pharma GmbH & Co.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.5 Trigemina Inc.
6.5.1 Trigemina Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.6 Abbott Laboratories
6.6.1 Abbott Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.7 Pfizer Inc.
6.7.1 Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.8 GlaxoSmithKline Plc.
6.8.1 GlaxoSmithKline Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.9 Novartis
6.9.1 Novartis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.10 Shire
6.10.1 Shire: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)

List of Figures

FIG. 1 Trigeminal Neuralgia Treatment Market: Research Methodology
FIG. 2 Global Trigeminal Neuralgia Treatment Market, by Treatment 2016 (US$ Mn)
FIG. 3 Global Trigeminal Neuralgia Treatment Market, by Geography, 2016 (Value %)
FIG. 4 Porter’s Five Forces Model: Trigeminal Neuralgia Treatment Market
FIG. 5 Attractive Investment Proposition, by Geography,2016
FIG. 6 Market Positioning of Key Trigeminal Neuralgia Treatment Market Players, 2016
FIG. 7 Anticonvulsant Market for Trigeminal Neuralgia Treatment, 2015 – 2025 (US$ Mn)
FIG. 8 NSAIDs Market for Trigeminal Neuralgia Treatment, 2015 – 2025 (US$ Mn)
FIG. 9 Opioids Market for Trigeminal Neuralgia Treatment, 2015 – 2025 (US$ Mn)
FIG. 10 Rhizotomy Market for Trigeminal Neuralgia Treatment, 2015 – 2025 (US$ Mn)
FIG. 11 Rhizotomy Market for Trigeminal Neuralgia Treatment, 2015 – 2025 (US$ Mn)
FIG. 12 Rhizotomy Market for Trigeminal Neuralgia Treatment, 2015 – 2025 (US$ Mn)
FIG. 13 North America Trigeminal Neuralgia Treatment Market , 2015 – 2025 (US$ Mn)
FIG. 14 Europe Trigeminal Neuralgia Treatment Market , 2015 – 2025 (US$ Mn)
FIG. 15 Asia-Pacific Trigeminal Neuralgia Treatment Market , 2015 – 2025 (US$ Mn)
FIG. 16 Latin America Trigeminal Neuralgia Treatment Market , 2015 – 2025 (US$ Mn)
FIG. 17 Middle East and Africa Trigeminal Neuralgia Treatment Market , 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global Trigeminal Neuralgia Treatment Market, By Treatment, 2015-2025 (US$ Mn)
TABLE 2 Drug based treatment market for Trigeminal Neuralgia, 2015-2025 (US$ Mn)
TABLE 3 Surgery based treatment market for Trigeminal Neuralgia, 2015-2025 (US$ Mn)
TABLE 4 Global Trigeminal Neuralgia Treatment Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 5 Allergen Plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 6 Biogen Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 7 Kineta Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments
TABLE 8 Merz Pharma GmbH & Co.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 9 Trigemina Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Development
TABLE 10 Abbot Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 11 Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 12 GlaxoSmithkline Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 13 Novartis : Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 14 Shire : Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)

Frequently Asked Question:

What is the size of Trigeminal Neuralgia Treatment Market?

The market for Trigeminal Neuralgia Treatment Market is expected to reach USD$ 99.17 Mn in 2025.

What is the Trigeminal Neuralgia Treatment Market CAGR?

The Trigeminal Neuralgia Treatment Market is expected to see significant CAGR growth over the coming years, at 7.60%.

What is the Forecast period considered for Trigeminal Neuralgia Treatment Market?

The report is forecasted from 2017 -2025.

What is the base year considered for Trigeminal Neuralgia Treatment Market?

The base year of this report is 2016.

Who are the major players in this market?

Allergan Plc,Biogen, Inc.,Kineta Inc.,Merz Pharma GmbH & Co.,Trigemina Inc. are some of the major players in the global market.

Antineoplastic Agents Market

Published:
Report ID: 36065

US Retail Pharmacy Market

Published:
Report ID: 32801

OTC Vitamins Dietary Supplements Market

Published:
Report ID: 35994

Liposomes Market

Published:
Report ID: 35888

UK Iron Supplement Market

Published:
Report ID: 35709

U.S. Iron Supplement Market

Published:
Report ID: 35688

Malignant Ascites Market

Published:
Report ID: 11184

Middle East and Africa In-Vitro Fertilization (IVF) Market

Published:
Report ID: 35578

Chronic Myeloid Leukemia (CML) Treatment Market

Published:
Report ID: 2939

Combination Therapies In Aesthetics Market

Published:
Report ID: 35434

CAR T-Cell Therapy Market

Published:
Report ID: 2051

OTC Cough Cold And Allergy Medicine Market

Published:
Report ID: 20062

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN